| __timestamp | Agios Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 18372000 |
| Thursday, January 1, 2015 | 141827000 | 15419000 |
| Friday, January 1, 2016 | 220163000 | 23844000 |
| Sunday, January 1, 2017 | 292681000 | 40376000 |
| Monday, January 1, 2018 | 341324000 | 75247000 |
| Tuesday, January 1, 2019 | 410894000 | 89017000 |
| Wednesday, January 1, 2020 | 367470000 | 114764000 |
| Friday, January 1, 2021 | 256973000 | 113864000 |
| Saturday, January 1, 2022 | 279910000 | 130991000 |
| Sunday, January 1, 2023 | 288903000 | 184353000 |
| Monday, January 1, 2024 | 301286000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Agios Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated have demonstrated contrasting strategies in their R&D investments.
Agios Pharmaceuticals has consistently prioritized R&D, with expenditures peaking in 2019 at approximately 41% higher than in 2014. Despite a slight decline post-2020, their investment remains robust, reflecting a strategic focus on pioneering therapies.
Conversely, Corcept Therapeutics has shown a remarkable increase in R&D spending, growing nearly tenfold from 2014 to 2023. This surge underscores their aggressive pursuit of new treatment avenues, particularly in the last five years.
These trends highlight the dynamic nature of biotech R&D, where strategic investments can drive innovation and market leadership.
Comparing Innovation Spending: Novo Nordisk A/S and Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
R&D Insights: How Neurocrine Biosciences, Inc. and Corcept Therapeutics Incorporated Allocate Funds
Comparing Innovation Spending: Bio-Techne Corporation and Agios Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Corcept Therapeutics Incorporated
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Opthea Limited
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Veracyte, Inc.
PTC Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Vericel Corporation and Agios Pharmaceuticals, Inc.
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.